Risk of gynecomastia and breast cancer associated with the use of 5-alpha reductase inhibitors for benign prostatic hyperplasia
Source: Clinical Epidemiology - Category: Epidemiology Tags: Clinical Epidemiology Source Type: research
More News: Benign Prostatic Hyperplasia | Breast Cancer | Cancer | Cancer & Oncology | Epidemiology | Gynecomastia